Efficacy and Safety of Trifluridine/Tipiracil (TAS-102) Combined With Bevacizumab and Serplulimab in Patients With Metastatic Colorectal Cancer Undergoing Cytoreductive Surgery: A Single-Arm, Single-Center Clinical Study
Clinical trial NCT06882915 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06882915
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-06
- Primary completion
- 2027-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.